Albemarle (ALB) insider sells 116 shares at $95 under 10b5-1

Albemarle Corporation (ALB) reported an insider transaction.

Rhea-AI Filing Summary

Albemarle Corporation (ALB) reported an insider transaction. On 10/09/2025, the company’s General Counsel & Secretary sold 116 shares of common stock at $95 per share in a transaction reported on Form 4. Following the sale, the reporting person beneficially owned 11,655 shares, held directly.

The filing notes the sale was made under a Rule 10b5-1 trading plan adopted on March 13, 2025, prior to the individual becoming an Executive Officer.

Insider Trade Summary

Net Seller: 116 shares

Net Sell 1 txn

Insider Krupa Ander C.

Role General Counsel & Sec

Sold 116 shs ($11K)

Type	Security	Shares	Price	Value
Sale	Common Stock	116	$95.00	$11K

Holdings After Transaction: Common Stock — 11,655 shares (Direct)

Footnotes (1)

1. F1. The sale reported in this Form 4 was effectuated pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025, prior to the Reporting Person becoming an Executive Officer.

FAQ

What did Albemarle (ALB) disclose in this Form 4?

An officer sold 116 shares of common stock at $95 on 10/09/2025 and now holds 11,655 shares directly.

Who is the reporting person in the ALB Form 4?

The reporting person is an Officer, serving as General Counsel & Secretary.

How many ALB shares were sold and at what price?

116 shares were sold at $95 per share.

How many ALB shares does the insider own after the transaction?

The insider beneficially owns 11,655 shares following the transaction.

Was the ALB sale under a Rule 10b5-1 plan?

Yes. The sale was made under a Rule 10b5-1 plan adopted on March 13, 2025.

Is this Form 4 filed by one or multiple reporting persons?

It was filed by one reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/14/2025 - 04:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Krupa Ander C.

(Last) (First) (Middle)

4250 CONGRESS STREET

SUITE 900

(Street)

CHARLOTTE NC 28209

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel & Sec

3. Date of Earliest Transaction (Month/Day/Year)
10/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/09/2025		S		116(1)	D	$95	11,655	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 was effectuated pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025, prior to the Reporting Person becoming an Executive Officer.

Remarks:

	/s/ Rebekah Richards, Attorney-in-Fact	10/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.